CANDIPHEN OVULOS C3 200MG KONJAC POLVO PRINCIPIO ACTIVO: GLIBENCLAMIDA

Description

PRINCIPIO ACTIVO: GLIBENCLAMIDA

Fabricada con hilo de algodón 60% y fibras sintéticas 40%

Tratamiento del carcinoma de células renales avanzado

Caja C/ 56 Monodosis

PRINCIPIO ACTIVO: LATANOPROST

CANDIPHEN OVULOS C3 200MG KONJAC POLVO PRINCIPIO ACTIVO: GLIBENCLAMIDASUSTANCIA: CANDIPHEN V OVULOS 200 MG. CAJA C 3 FABRICANTE: PIMDR PHARMA

Exchange/Return Notes

We offer a 30-day return/exchange service after receiving.
Final sale items are not eligible for returns or exchanges.
To process your return/exchange, please contact us at [email protected]
Please click here for more details>>> Return & Exchange Policy